Bigfoot Biomedical announced on 17 March that it has secured $57m in combined debt and equity financing from Madryn Asset Management LP, an alternative asset management firm. The company says it has raised more than $200m to date.
The Milpitas, CA-based diabetes company said it plans to use the financing to support the commercialization of its
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?